---
title: "THOMPSON CYNTHIA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/fd28a6c8-ada0-5484-a589-e34eedd132d0
json: https://whiteintel.dev/api/public/dossier/fd28a6c8-ada0-5484-a589-e34eedd132d0
identifier: sec:0001095405
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# THOMPSON CYNTHIA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001095405`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/fd28a6c8-ada0-5484-a589-e34eedd132d0  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/fd28a6c8-ada0-5484-a589-e34eedd132d0  

## Ownership & control

### Holdings / subsidiaries

- **SAMARITAN PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/63c99b9d-7fa5-5e89-a0a5-30c786392bce

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **THOMPSON CYNTHIA**. Human view: https://whiteintel.dev/entity/fd28a6c8-ada0-5484-a589-e34eedd132d0 · Structured JSON: https://whiteintel.dev/api/public/dossier/fd28a6c8-ada0-5484-a589-e34eedd132d0._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._